Arvin Yang's most recent trade in Mersana Therapeutics Inc was a trade of 217,500 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mersana Therapeutics Inc | Arvin Yang | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 217,500 | 217,500 | - | - | Stock option (right to buy) | |
| Mersana Therapeutics Inc | Arvin Yang | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 48,333 | 48,333 | - | - | Restricted stock unit | |
| Mersana Therapeutics Inc | Arvin Yang | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,084 | 21,249 | - | - | Restricted stock unit | |
| Mersana Therapeutics Inc | Arvin Yang | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,084 | 33,030 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Arvin Yang | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 2,209 | 30,821 (0%) | 0% | 5.7 | 12,680 | Common Stock |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 18,500 | 0 | - | - | Restricted stock unit | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 18,500 | 31,473 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.59 per share. | 30 Nov 2022 | 5,527 | 25,946 (0%) | 0% | 6.6 | 36,423 | Common Stock |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 127,500 | 127,500 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 28,333 | 28,333 | - | - | Restricted Stock Units | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 18,500 | 18,500 | - | - | Restricted Stock Units | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 18,500 | 18,500 (0%) | 0% | - | Common Stock | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.81 per share. | 30 Nov 2021 | 5,527 | 12,973 (0%) | 0% | 6.8 | 37,639 | Common Stock |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 37,000 | 37,000 | - | - | Restricted stock unit |